Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome

New England Journal of Medicine

Volumn 338, Issue 4, 1998, Pages 209-216

  Schmidt, Peter J ^a   Nieman, Lynnette K ^b   Danaceau, Merry A ^c   Adams, Linda F ^a   Rubinow, David R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; LEUPRORELIN; PROGESTERONE;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; IRRITABILITY; OVARY FUNCTION; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EMOTIONS; ESTRADIOL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HOT FLASHES; HUMANS; LEUPROLIDE; MIDDLE AGED; PREMENSTRUAL SYNDROME; PROGESTERONE;

EID: 0032556992     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199801223380401     Document Type: Article

References (29)

1. Schmidt PJ, Nieman LK, Grover GN, Muller KL, Merriam GR, Rubinow DR. Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N Engl J Med 1991;324:1174-9.
2. Muse KN, Cetel NS, Futterman LA, Yen SSC. The premenstrual syndrome: effects of "medical ovariectomy." N Engl J Med 1984;311:1345-9.
3. Hammarback S, Backstrom T. Induced anovulation as a treatment of premenstrual tension syndrome: a double-blind cross-over study with GnRH-agonist versus placebo. Acta Obstet Gynecol Scand 1988;67:159-66.
4. Brown CS, Ling FW, Andersen RN, Farmer RG, Arheart KL. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Obstet Gynecol 1994;84:779-86.
5. West CP, Hillier H. Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (Zoladex) in management of the premenstrual tension syndrome. Hum Reprod 1994;9:1058-63.
6. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured clinical interview for DSM-III-R - patient edition (SCID, version 1.0). Washington, D.C.: American Psychiatric Press, 1990.
7. Rubinow DR, Roy-Byrne PP, Hoban MC, Gold PW, Post RM. Prospective assessment of menstrually related mood disorders. Am J Psychiatry 1984;141:684-6.
8. Schnurr PP. Measuring amount of symptom change in the diagnosis of premenstrual syndrome. Psychol Assess 1989;1:277-83.
9. Idem. Some correlates of prospectively defined premenstrual syndrome. Am J Psychiatry 1988;145:491-4.
10. Endicott J, Halbreich U. Retrospective report of premenstrual depressive changes: factors affecting confirmation by daily ratings. Psychopharmacol Bull 1982;18(3):109-12.
11. Halbreich U, Endicott J, Lesser J. The clinical diagnosis and classification of premenstrual changes. Can J Psychiatry 1985;30:489-97.
12. Diagnostic and statistical manual of mental disorders, 4th ed.: DSM-IV. Washington, D.C.: American Psychiatric Association, 1994.
13. Hurt SW, Schnurr PP, Severino SK, et al. Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. Am J Psychiatry 1992;149:525-30.
14. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
15. Spielberger CD. State-trait anxiety inventory for adults: sampler set: manual, test, scoring key. Palo Alto, Calif: Mind Garden, 1983.
16. Steiner M, Haskett RF, Carroll BJ. Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales. Acta Psychiatr Scand 1980;62:177-90.
17. Abraham GE, Swerdloff R, Tulchinsky D, Odell WD. Radioimmunoassay of plasma progesterone. J Clin Endocrinol Metab 1971;32:619-24.
18. Jiang NS, Ryan RJ. Radioimmunoassay for estrogens: a preliminary communication. Mayo Clin Proc 1969;44:461-5.
19. Haskett RF, Abplanalp JM. Premenstrual tension syndrome: diagnostic criteria and selection of research subjects. Psychiatry Res 1983;9:125-38.
20. Casper RF, Powell AM. Premenstrual syndrome: documentation by a linear analog scale compared with two descriptive scales. Am J Obstet Gynecol 1986;155:862-7.
21. Hussain SY, Massil JH, Matta WH, Shaw RW, O'Brien PMS. Buserelin in premenstrual syndrome. Gynecol Endocrinol 1992;6:57-64.
22. Mortola JF, Girton L, Fischer U. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab 1991;72:252A-252F.
23. Bancroft J, Boyle H, Warner P, Fraser HM. The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes. Clin Endocrinol (Oxf) 1987;27:171-82.
24. Mezrow G, Shoupe D, Spicer D, Lobo R, Leung B, Pike M. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome. Fertil Steril 1994;62:932-7.
25. Sarno AP Jr, Miller EJ Jr, Lundblad EG. Premenstrual syndrome: beneficial effects of periodic, low-dose danazol. Obstet Gynecol 1987;70:33-6.
26. Freeman E, Rickels K, Sondheimer SJ, Polansky M. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. JAMA 1990;264:349-53.
27. Halbreich U, Endicott J, Goldstein S, Nee J. Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand 1986;74:576-86.
28. Redei E, Freeman EW. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Psychoneuroendocrinology 1995;20:259-67.
29. Wang M, Seippel L, Purdy RH, Bäckström T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one. J Clin Endocrinol Metab 1996;81:1076-82.